Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease

Internal Medicine Journal

Volumn 37, Issue 3, 2007, Pages 190-192

  Grigg, A ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Hydroxyurea; Sickle cell; Spermatogenesis

Indexed keywords

HYDROXYUREA;

ADULT; AZOOSPERMIA; CASE REPORT; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG INDICATION; FERTILIZATION; HUMAN; MALE; MYELOPROLIFERATIVE DISORDER; PREGNANCY TERMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEMEN ANALYSIS; SICKLE CELL ANEMIA; SPERMATOGENESIS; SPERMATOZOON ABNORMALITY; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; AZOOSPERMIA; HUMANS; HYDROXYUREA; MALE; MYELOPROLIFERATIVE DISORDERS; NUCLEIC ACID SYNTHESIS INHIBITORS; OLIGOSPERMIA; RETROSPECTIVE STUDIES; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA;

EID: 33846983200     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01290.x     Document Type: Review

References (13)

1. Charache S, Dover GJ, Moyer MA, Moore JW. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood 1987; 69: 109-16.
2. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995; 332: 1317-22.
3. Lu CC, Melstrich ML. Cytotoxic effects of chemotherapeutic drugs on mouse testis cells. Cancer Res 1979; 39: 3575-82.
4. Evenson DP, Jost LK. Hydroxyurea exposure alters mouse testicular kinetics and sperm chromatin structure. Cell Prolif 1992; 26: 147-59.
5. Fiscor G, Ginsberg LC. The effect of hydroxyurea and mitomycin C on sperm motility in mice. Mutat Res 1980; 70: 383-7.
6. Chapman RM. Effect of cytotoxic therapy on sexuality in gonadal function. Semin Oncol 1982; 9: 84-94.
7. Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA et al. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 2004; 102: 2039-45.
8. Ferster A, Tahriri P, Vermylen C, Sturbois G, Corazza F, Fondu P et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001; 97: 3628-32.
9. Garozzo G, Disca S, Fidone C, Bonomo P. Azoospermia in a patient with sickle cell disease treated with hydroxyurea. Haematologica 2000; 85: 1216-17.
10. Osegbe DN, Akinyanju O, Amaku EO. Fertility in males with sickle cell disease. Lancet 1981; 2: 275-6.
11. Agbaraji VO, Scott RB, Leto S, Kinslow LW. Fertility studies in sickle cell disease: semen analysis in adult male patients. Int J Fertil 1988; 33: 347-52.
12. Thomson AB, Campbell AJ, Irvine DS, Anderson RA, Kelnar CJH, Wallace WHB. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case control study. Lancet 2002; 360: 361-7.
13. Byrne J, Rasmussen SA, Steinhorn SC, Connelly RR, Myers MH, Lynch CF et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 1998; 62: 45-52.